...
首页> 外文期刊>Translational Oncology >Isolation of Stem-Like Cancer Cells in Primary Endometrial Cancer Using Cell Surface Markers CD133 and CXCR4
【24h】

Isolation of Stem-Like Cancer Cells in Primary Endometrial Cancer Using Cell Surface Markers CD133 and CXCR4

机译:使用细胞表面标志物CD133和CXCR4分离原发性子宫内膜癌中的干细胞样癌细胞

获取原文
           

摘要

Endometrial cancer (EC) is the most common familiar gynecologic malignant tumor identified in the female reproductive system and has been increasing yearly. In this study, we will identify the surface markers and stem cell markers related with cancer stem cells (CSCs) of EC. Tissue samples were obtained from endometrial cancer patients during surgical procedures. Single cells were isolated from the tissues for culturing, transfection into nude mice, and histopathology analysis. RT-PCR demonstrated that the cultured cells strongly expressed stemness-related genes, such as c-Myc , Sox-2 , Nanog , Oct 4A , ABCG2 , BMI-1 , CK-18 , Nestin and β-actin . The expression of surface markers CD24, CD133, CD47, CD29, CD44, CXCR4, SSEA3 and SSEA4, CD24, and CD133 and chemokine markers such as CXCR4 were measured by flow cytometry. Then the double percentage of CD133+CXCR4+ cells constituted 7.2% and 9.3% in EC cells originated from two different patients, respectively. The CD133+CXCR4+ primary endometrial cancer cells grew faster, exhibited high expression of mRNA of stemness-related genes, produced more spheres, and had higher clonogenic ability than other subpopulations. They are also more resistant to anti-cancer drugs than other subpopulations. These findings indicate that CD133+CXCR4+ cells may possess some characteristics of CSCs in primary endometrial cancer. These cell surface markers may be useful for the development of drugs against CSC molecular targets or as a predictive marker for poor prognosis in primary endometrial cancer.
机译:子宫内膜癌(EC)是女性生殖系统中最常见的妇科恶性肿瘤,并且每年都在增加。在这项研究中,我们将鉴定与EC的癌症干细胞(CSC)相关的表面标记和干细胞标记。在手术过程中从子宫内膜癌患者获得组织样品。从组织中分离出单细胞用于培养,转染到裸鼠中以及进行组织病理学分析。 RT-PCR显示培养的细胞强烈表达与干性相关的基因,例如c-Myc,Sox-2,Nanog,Oct 4A,ABCG2,BMI-1,CK-18,Nestin和β-肌动蛋白。通过流式细胞术测量表面标志物CD24,CD133,CD47,CD29,CD44,CXCR4,SSEA3和SSEA4,CD24和CD133的表达以及趋化因子标志物如CXCR4的表达。然后,来自两个不同患者的EC细胞中,CD133 + CXCR4 +细胞的两倍百分比分别占7.2%和9.3%。与其他亚群相比,CD133 + CXCR4 +原发性子宫内膜癌细胞生长更快,表现出与干性相关基因的mRNA高表达,产生更多的球体,并具有更高的克隆能力。与其他亚群相比,它们对抗癌药的抵抗力也更高。这些发现表明,CD133 + CXCR4 +细胞在原发性子宫内膜癌中可能具有CSC的某些特征。这些细胞表面标志物可用于开发针对CSC分子靶标的药物,或作为原发性子宫内膜癌预后不良的预测标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号